Qiang Li

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Dongsheng Yue, Shidong Xu, Qun Wang et al. · The Lancet Respiratory Medicine · 2018 · 288 citations

Medicine, Pathology, Erlotinib Versus Vinorelbine +8

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

Julien Dilly, Megan T. Hoffman, Laleh Abbassi et al. · Cancer Discovery · 2024 · 182 citations · Full text

Kras Inhibitors, Pancreatic Cancer, Oncogenic Agent +13

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

Dong Hui, Qiang Li, Jian Wang et al. · Digestive and Liver Disease · 2008 · 150 citations

Surgical Oncology, Cancer Immunosurveillance, Hepatology +8

Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer

Yunlong Cui, Huikai Li, Hong-Yuan Zhou et al. · Asian Pacific Journal of Cancer Prevention · 2013 · 91 citations · Full text

Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma

Xiaohong Shen, Na Li, Hui Li et al. · Journal of Cancer Research and Clinical Oncology · 2010 · 90 citations · Full text

Cancer Immunosurveillance, Hepatology, Hepatocellular Carcinoma +10